PRF Technologies (PRFX) Other Non-Current Liabilities (2020 - 2025)
PRF Technologies (PRFX) recorded quarterly Other Non-Current Liabilities of $267000.0 in Q4 2025, up 3.09% on a QoQ basis from $259000.0 in Q4 2024, and up 3.09% year-over-year from $259000.0 in Q4 2024.
PRF Technologies (PRFX) Other Non-Current Liabilities (2020 - 2025) Analysis & Trends
PRF Technologies has disclosed Other Non-Current Liabilities across 6 years of filings, most recently posting $267000.0 for Q4 2025.
- Quarterly Other Non-Current Liabilities rose 3.09% year-over-year to $267000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $267000.0 (up 3.09% YoY) and the FY2025 annual result came in at $267000.0, up 3.09% from the prior year.
- Other Non-Current Liabilities climbed to $267000.0 in Q4 2025, from $259000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $863000.0 in Q3 2023 and troughed at $234000.0 in Q4 2021.
- A 5-year average of $352833.3 and a median of $255000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2021 — Other Non-Current Liabilities increased 6.36% — and 2025, when it climbed 3.09%.
- Tracing PRFX's Other Non-Current Liabilities over 5 years: stood at $234000.0 in 2021, then grew by 3.85% to $243000.0 in 2022, then grew by 3.29% to $251000.0 in 2023, then gained by 3.19% to $259000.0 in 2024, then climbed by 3.09% to $267000.0 in 2025.
- Business Quant data shows PRFX's Other Non-Current Liabilities at $267000.0 in Q4 2025, $259000.0 in Q4 2024, and $251000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 267,000.00 |
| Dec 31, 2024 | 259,000.00 |
| Dec 31, 2023 | 251,000.00 |
| Sep 30, 2023 | 863,000.00 |
| Dec 31, 2022 | 243,000.00 |
| Dec 31, 2021 | 234,000.00 |
| Dec 31, 2020 | 220,000.00 |